Pacific Biosciences of California Inc
NASDAQ:PACB
Wall Street
Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for
PACB
is 6.08 USD
.
PACB Last Price Targets
Pacific Biosciences of California Inc
The latest public price target was made on Apr 18, 2024 by
Matthew Sykes
from
Goldman Sachs
,
who expects
PACB
stock to
rise by 70%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Matthew Sykes
Goldman Sachs
|
2.5
USD
Upside 70% |
1 week ago
Apr 18, 2024
|
Goldman Sachs Downgrades Pacific Biosciences of California (PACB) to Neutral
StreetInsider
|
Kyle Mikson
Canaccord Genuity
|
3.5
USD
Upside 138% |
1 week ago
Apr 16, 2024
|
PacBio price target lowered to $3.50 from $10 at Canaccord
TheFly
|
Price Targets
Revenue
Forecast
Revenue Estimate
Pacific Biosciences of California Inc
For the last 8 years the
compound annual growth rate for
Pacific Biosciences of California Inc's revenue is
10%.
The projected
CAGR
for the next 3 years is
35%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PACB's stock price target?
Price Target
6.08
USD
According to Wall Street analysts, the average 1-year price target for
PACB
is 6.08 USD
.
What is Pacific Biosciences of California Inc's Revenue forecast?
Projected CAGR
35%
For the last 8 years the
compound annual growth rate for
Pacific Biosciences of California Inc's revenue is
10%.
The projected
CAGR
for the next 3 years is
35%.
You don't have any saved screeners yet
